Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Deutsche Bank’s days on Euro Stoxx 50 benchmark may be numbered

2018-07-05 thestar.com.my
In peril: Germany’s biggest bank has lost more than 40 of its value this year after chalking up its third straight annual loss. — Reuters
KER DB ENGI PPRUY PPRUF

3
Chanel opens its books for first time to reveal a $66 billion fortune

2018-06-21 nzherald.co.nz
Chanel, known for No. 5 perfume, little black dresses and financial secrecy, opened its books for the first time to reveal almost US$10 billion ($1.45b) in sales last year - a level that rivals luxury leader Louis Vuitton.
KER HESAY PPRUY HESAF PPRUF NYTAB

28
Canada Goose Holdings (GOOS) Hit Fresh Highs: Is There Still Room to Run?

2018-06-21 zacks
Have you been paying attention to shares of Canada Goose Holdings (GOOS - Free Report) ? Shares have been on the move with the stock up 60.2% over the past month. GOOS hit a new 52-week-high of $68.75 in the previous session. Canada Goose Holdings has gained 102.8% since the start of the year compared to the 14.5% move for the Retail-Wholesale sector and the 7.6% year-to-date return for its peer group.
GOOS PPRUY CECO MS.PRE MS.PRF MS.PRG MS.PRA KER MS.PRI SCVL MS.PRK MUR.WI MUR PPRUF URBN ENVA MS

12
Canada Goose (GOOS) Hits a 52-Week High, Can the Run Continue?

2018-06-13 zacks
Have you been paying attention to shares of Canada Goose Holdings (GOOS - Free Report) ? Shares have been on the move with the stock up 14.5% over the past month. GOOS hit a new 52-week high of $45.07 in the previous session. Canada Goose Holdings has gained 41.9% since the start of the year compared to the 13.8% move for the Retail-Wholesale sector and the 4.1% year-to-date return for its peer group.
GOOS KER VRNT SCVL PPRUY KMG PPRUF URBN

12
Urban Outfitters (URBN) Soars to a 52-Week High, Time to Cash Out?

2018-06-13 zacks
Have you been paying attention to shares of Urban Outfitters (URBN - Free Report) ? Shares have been on the move with the stock up 17.4% over the past month. URBN hit a new 52-week high of $48.10 in the previous session. Urban Outfitters has gained 36.6% since the start of the year compared to the 13.8% move for the Retail-Wholesale sector and the 4.1% year-to-date return for its peer group.
GOOS KER VRNT SCVL PPRUY KMG PPRUF URBN

0
Prada Gets It. Luxury Needs the Digital Rich Kids - Bloomberg

2018-06-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
KER PPRUY PPRUF

2
Gucci Aims to Rival Louis Vuitton With $12 Billion Target - Bloomberg

2018-06-07 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
KER HESAY PPRUY HESAF PPRUF

5
Rimowa Has Made a Transparent Suitcase - Bloomberg

2018-06-05 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
KER NKE PPRUY PPRUF

17
‘Retailpocalypse’ Has Ended: Buy Macy’s, Evercore Says - Bloomberg

2018-06-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
PANDY GOOS ADDDF ADDYY PPRUY RL PNDZF ROST PNDZY PVH KER LULU PPRUF HBI

0
Gucci Strikes China Gold, Thanks to ‘Moonlight Clans’ Who Spend It All - Bloomberg

2018-05-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
KER PPRUY PPRUF

0
Kering SA: The Management's Focus On 'La Luxe' Could Make Investor Returns Go Through The Roof

2018-05-01 seekingalpha
Kering SA is one of the oldest and largest French luxury conglomerates and the parent company of brands such as Gucci, Saint Laurent, Bottega Veneta, and so on.
KER PPRUY PPRUF

0
Balenciaga issues second apology after claims of discrimination against Chinese shoppers

2018-04-28 channelnewsasia
BEIJING: Fashion house Balenciaga, owned by French luxury group Kering SA, issued a second, longer apology after reports of a scuffle between Chinese and other shoppers in a Paris shop led to claims in China of racial discrimination by store staff.
KER PPRUY PPRUF

0
Court rules Saint Laurent’s ex-star designer was underpaid by millions

2018-04-05 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
KER PPRUY PPRUF

43
PRESS DIGEST- New York Times business news - March 22

2018-03-22 reuters
March 22 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
FB KER PPRUY MDPEB PPRUF NYTAB MDP TIME

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:KER / KERING on message board site Silicon Investor.

RON STRUTHERS: BEST STOCK PICKER Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG
Medved QuoteTracker - real-time portfolio tracker The Justa and Lars Honors Bob Brinker Investment Club Thread
[email protected] u0026 TRUTHSEEKER Expose Crims u0026 Scammers!!! Lurkers Only
Whodunit? Two Stockbrokers Murdered in Jersey; No Clues IDRA Baker Bros on board u0026 Vincent Millano
Interactive Brokers / Timberhill Interactive Brokers